危重症患者的铁蛋白升高
该回顾性观察研究纳入柏林Charité大学医院成人外科、麻醉和内科ICU在2006年1月至2018年8月期间收治的≥18岁、至少有一次铁蛋白值且铁蛋白升高(≥500 µg/L)的危重症患者。2,623例铁蛋白升高患者中40例(1.52%)诊断为HLH,诊断基于HLH-2004标准和HScore。HLH患者最高铁蛋白水平高于所有其他疾病组(各p<0.001),脓毒症和脓毒性休克患者最高铁蛋白水平高于其他诊断患者(各p<0.001)。最高铁蛋白9,083 µg/L诊断HLH的敏感性92.5%、特异性91.9%(AUC 0.963,95%CI 0.949-0.978);最高铁蛋白与院内死亡增加相关(OR 1.518每log µg/L,95%CI 1.384-1.665每log µg/L;p<0.001)。作者认为铁蛋白水平有助于在ICU中改善HLH诊断,将铁蛋白纳入脓毒症实验室检查组合是有依据的。
要点
- 2,623例铁蛋白升高(≥500 µg/L)的成人ICU患者中,40例(1.52%)符合HLH-2004标准和HScore诊断的HLH。
- HLH患者最高铁蛋白水平高于所有其他疾病组(各p<0.001),脓毒症和脓毒性休克患者最高铁蛋白水平高于其他诊断患者(各p<0.001)。
- 最高铁蛋白9,083 µg/L诊断HLH的敏感性92.5%、特异性91.9%(AUC 0.963,95%CI 0.949-0.978)。
- 最高铁蛋白与院内死亡增加相关(OR 1.518每log µg/L,95%CI 1.384-1.665每log µg/L;p<0.001)。
- 其他诊断亚组中,最高铁蛋白水平最高者为水痘-带状疱疹病毒、肝炎或疟疾患者(中位数分别为1,935、1,928和1,587 µg/L)。
适用人群与场景
- 柏林Charité大学医院成人外科、麻醉和内科ICU在2006年1月至2018年8月期间收治的危重症患者。
- 年龄≥18岁,至少有一次铁蛋白值且铁蛋白升高(≥500 µg/L)。
诊断标准与关键阈值
- HLH诊断基于HLH-2004标准和HScore。
- 铁蛋白升高定义为≥500 µg/L。
- 最高铁蛋白9,083 µg/L诊断HLH的敏感性92.5%、特异性91.9%(AUC 0.963,95%CI 0.949-0.978)。
研究设计与关键结果
- 回顾性观察研究,纳入2,623例铁蛋白升高(≥500 µg/L)的成人ICU患者,其中40例(1.52%)诊断为HLH。
- HLH患者最高铁蛋白水平高于所有其他疾病组(各p<0.001)。
- 脓毒症和脓毒性休克患者最高铁蛋白水平高于其他诊断患者(各p<0.001)。
- 最高铁蛋白9,083 µg/L诊断HLH的敏感性92.5%、特异性91.9%(AUC 0.963,95%CI 0.949-0.978)。
- 其他诊断亚组中,最高铁蛋白水平最高者为水痘-带状疱疹病毒、肝炎或疟疾患者(中位数分别为1,935、1,928和1,587 µg/L)。
- 最高铁蛋白与院内死亡增加相关(OR 1.518每log µg/L,95%CI 1.384-1.665每log µg/L;p<0.001)。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,最高铁蛋白9,083 µg/L具有高敏感性和特异性,可能有助于改善ICU中HLH的诊断。
- 作者认为,将铁蛋白纳入脓毒症实验室检查组合是有依据的。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Hyperferritinemia is frequently seen in critically ill patients. A rather rare though life-threatening condition related to severely elevated ferritin is hemophagocytic lymphohistiocytosis. We analyze ferritin levels to differentiate hemophagocytic lymphohistiocytosis from other causes of hyperferritinemia in a mixed cohort of critically ill patients.
DESIGN: Retrospective observational study.
SETTING: Adult surgical, anesthesiologic, and medical ICUs of a university hospital.
PATIENTS: Critical care patients (≥ 18 yr old) admitted to any of the adult ICUs at Charité - Universitätsmedizin Berlin between January 2006 and August 2018 with at least one ferritin value and hyperferritinemia (≥ 500 µg/L).
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Patients were categorized into hemophagocytic lymphohistiocytosis, sepsis, septic shock, and other diagnoses. These were further categorized into 17 subgroups. Hemophagocytic lymphohistiocytosis diagnosis was based on Hemophagocytic Lymphohistiocytosis-2004 criteria and the HScore. Of 2,623 patients with hyperferritinemia, 40 were considered to have hemophagocytic lymphohistiocytosis (1.52%). Maximum ferritin levels were highest in hemophagocytic lymphohistiocytosis patients compared with all other disease groups (each p < 0.001). Sepsis and septic shock patients had higher maximum ferritin levels than patients with other diagnoses (each p < 0.001). A maximum ferritin value of 9,083 µg/L was at 92.5% sensitivity and 91.9% specificity for hemophagocytic lymphohistiocytosis (area under the curve, 0.963; 95% CI, 0.949-0.978). Of all subgroups with other diagnoses, maximum ferritin levels were highest in patients with varicella-zoster virus, hepatitis, or malaria (median, 1,935, 1,928, and 1,587 µg/L, respectively). Maximum ferritin levels were associated with increased in-hospital mortality (odds ratio, 1.518 per log µg/L [95% CI, 1.384-1.665 per log µg/L]; p < 0.001).
CONCLUSIONS: This is the largest study of patients with ferritin available in a mixed ICU cohort. Ferritin levels in patients with hemophagocytic lymphohistiocytosis, sepsis, septic shock, and other conditions were distinctly different, with the highest ferritin levels observed in hemophagocytic lymphohistiocytosis patients. Maximum ferritin of 9,083 µg/L showed high sensitivity and specificity and, therefore, may contribute to improved diagnosis of hemophagocytic lymphohistiocytosis in ICU. The inclusion of ferritin into the sepsis laboratory panel is warranted.
参考来源
- Lachmann G, Knaak C, Vorderwülbecke G, et al. Hyperferritinemia in Critically Ill Patients. Crit Care Med. 2020. PMID: 32205591. doi:10.1097/CCM.0000000000004131
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。